← Leaderboards
Robert McBride
Felix Biotechnology, Inc.
$798,835
Attributed
$798,835
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $614.4K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$798,835 · 2
By mechanism
R41$484,424 · 1
R43$314,411 · 1
Top collaborators
No co-investigators on record.
Most similar at Felix Biotechnology, Inc.
Same institution · by research overlap
- Robert McBride$256,000
Others in their field
Other Rising Stars on “Biotechnology”
- Gene Garrard Olinger · University Of Texas Med Br Galveston$23,000,000
- Cyrus Wadia · Activate Global, Inc.$7,489,493
- Aimee Rose · Activate Global, Inc.$7,489,493
- James M Balkovec · Hackensack University Medical Center$5,119,595
- Michael P Weiner · Abbratech, Inc.$4,657,862
- Oren Rom · Lsu Health Sciences Center -Shreveport$3,749,984
Research focus
BiotechnologyBacteriophagesTechnologyCellsInfectionBar CodesLyticSmall MoleculeAntibioticsCommercializationEngineeringFda ApprovedClustered Regularly Interspaced Short Palindromic RepeatsBaseFitnessDensityClinicAntibiotic Resistant InfectionsEfficacious TreatmentClinical ApplicationClinical DevelopmentClinical TrialsAssay DevelopmentBiology
Grant awards (3)
Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization$184,424
R41 · FY2023 · AI · contact PI
Microfluidics Platform for Rapid, High-throughput Screening of Therapeutic Bacteriophages Based on Patient Bacterial Isolates$314,411
R43 · FY2022 · GM · contact PI
Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization$300,000
R41 · FY2022 · AI · contact PI